IVIXFInvion Ltd

About Invion Ltd (IVIXF)

Invion Ltd (IVIXF) is a Drug Manufacturers - Specialty & Generic company headquartered in South Melbourne, VA, Australia whose shares trade over-the-counter on the Pink tier.

Invion's expertise and assets target chronic inflammation in two key areas of human health chronic inflammatory airway disease (or respiratory disease), and inflammation caused by autoimmune disease. Invion aims to grow a diverse business with a broad pipeline of drug assets that target better patient outcomes and major commercial opportunities. The Group has three drug assets in development, and three phase II clinical trials, regulated by the Food & Drug Administration (FDA), currently underway in the United States.

IVIXF key facts

Ticker symbol

IVIXF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

South Melbourne, VA, Australia

Country of incorporation

AU

Employees

8

Estimated market cap

$237.06M (as of May 12, 2025)

Shares outstanding

6,424,407,069

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with I